insights_auto
Why is INCY down 2,14%?
Dive Deeperchevron_right
INCY:NASDAQ
Incyte Corp
118,76 $
arrow_downward
-2,14%(-2,60) 1D
1 қаз., 12:49:34 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
120,47 $
High
121,22 $
Low
118,34 $
Mkt. cap
24,07 млрд
Avg. vol.
1,42 млн
Volume
628,38 м.
P/E ratio
15,13
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
Open
120,47 $
High
121,22 $
Low
118,34 $
Mkt. cap
24,07 млрд
Avg. vol.
1,42 млн
Volume
628,38 м.
P/E ratio
15,13
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
GuruFocus
·
3 сағат бұрын
INCY Maintained by Wells Fargo -- Price Target Raised to $128
StockStory
·
5 сағат бұрын
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
AD HOC NEWS
·
10 сағат бұрын
Incyte stock pre-market at EUR 107.65: plus 0.51 percent
News Corp
·
19 сағат бұрын
Incyte Corp. stock outperforms competitors despite losses on the day
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com